Business
Additional Subscription
Cellbxhealth plc announced an additional subscription by Conifer Management, LLC, on behalf of the Acacia funds, for 40,891,541 New Ordinary Shares at the Issue Price, raising approximately £0.4 million. This brings the total gross proceeds from the fundraising, including this additional subscription, to approximately £8.2 million. Following this, Acacia will hold 29.9% of the issued share capital. The enlarged share capital post-Second Admission is expected to be 1,139,402,658 New Ordinary Shares, with Second Admission anticipated on December 18, 2025. Disclaimer*
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\nTHIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF CELLBXHEALTH PLC.\n2 December 2025\nCELLBXHEALTH plc (the \"Company\")\nAdditional Subscription\nCELLBXHEALTH plc (AIM: CLBX), a leader in circulating tumour cell (CTC) intelligence is pleased to announce that further to the closing of the Retail Offer yesterday, Conifer Management, LLC, on behalf of the Acacia funds (\"Acacia''), has subscribed for a further 40,891,541 New Ordinary Shares at the Issue Price (\"Additional Subscription Shares\") by way of a direct subscription (\"Additional Subscription\"), raising further gross proceeds of approximately £0.4 million.\nAcacia was the largest participant in the Fundraising and the Additional Subscription allows Acacia to ensure that it will hold 29.9% of the issued share capital following Second Admission.\n \nThe Fundraising (including the Additional Subscription) has raised, in aggregate, gross proceeds of approximately £8.2 million.\n \nSubject to the passing of the Resolutions, the Additional Subscription Shares will be included in the Second Admission which will now be in respect of, in aggregate, 807,670,990 New Ordinary Shares comprising the Second Tranche Placing Shares, the Subscription Shares, the Retail Offer Shares and the Additional Subscription Shares. Second Admission is expected to occur at 8.00 a.m. on 18 December 2025 (or such later time and/or date as the Company and Cavendish may agree (being no later than 8.00 a.m. on 16 January 2026)).\n\n\nThe issued share capital of the Company following Second Admission (the \"Enlarged Share Capital\") will now be a total of 1,139,402,658 New Ordinary Shares.\n \nCavendish Capital Markets Limited (\"Cavendish\") acted as Nominated Adviser, Broker and Bookrunner in...